Abstract:Delivering vectorized information into cells with the help of viruses has been of high interest to fundamental and applied science, and bears significant therapeutic promise. Human adenoviruses (HAdVs) have been at the forefront of gene delivery for many years, and the subject of intensive development resulting in several generations of agents, including replication-competent, -defective or retargeted vectors, and recently also helper-dependent (HD), so-called gutless vectors lacking any viral protein coding information. While it is possible to produce HD-AdVs in significant amounts, physical properties of these virus-like particles and their efficiency of transduction have not been addressed. Here we used single-cell and single virus particle assays to probe the effect of genome length on HadV-C5 vector transduction. Our results demonstrate that first generation C5 vectors lacking the E1/E3 regions of the viral genome as well as HD-AdV-C5 particles with a wild type ~36 kbp or an undersized double-strand DNA genome are similar to HAdV-C5 wild-type regarding attachment to human lung epithelial cells, endocytic uptake, endosome penetration and dependency on the E3 RING ubiquitin ligase Mind Bomb 1 for DNA uncoating at the nuclear pore complex. Atomic force microscopy measurements of single virus particles indicated that small changes in the genome length from 94-103 percent of HAdV-C5 have no major impact on physical and mechanical features of AdV vectors. In contrast, an HD-AdV-C5 with ~30 kbp genome was slightly stiffer and less heat-resistant than the other particles, despite comparable entry and transduction efficiencies in tissue culture cell lines, including murine alveolar macrophage-like MPI-2 cells. Together, our in vitro studies reinforce the use of HD-AdV vectors for effective single round gene delivery. The results illustrate how physical properties and cell entry behaviour of single virus particles can provide functional information for anticipated therapeutic vector applications.

[Advances in Helper-Dependent Adenoviral Vector--a Review Review].

Progress and prospects: gene therapy for genetic diseases with helper-dependent adenoviral vectors

Gene therapy with helper-dependent adenoviral vectors: lessons from studies in large animal models

Enhanced Growth of Recombinant Human Adenovirus Type 41 (Hadv-41) Carrying ADP Gene

HDAd6/35++ - a new helper-dependent adenovirus vector platform for in vivo transduction of hematopoietic stem cells.

Construction of retargeting helper adenovirus and its functions

Adeno‐associated Virus Vectors for Gene Therapy—focusing on Melanoma

Advances of Recombinant Adenoviral Vectors in Preclinical and Clinical Applications

Adenoviral Vector System: A Comprehensive Overview of Constructions, Therapeutic Applications and Host Responses

In vitro transgenic expression efficacy of a helper-dependent adenoviral vector encoding enhanced green fluorescent protein]

[Trends in Development of Self-Complementary Adeno-Associated Virus Vector].

Clinical Application of Adenovirus (AdV): A Comprehensive Review

The Adeno-associated Virus - A Safe and Promising Vehicle for Liverspecific Gene Therapy of Inherited and Non-inherited Disorders

Adenoviral Vectors for Gene Therapy of Hereditary Diseases

Gutless helper-dependent and first generation HAdV5 vectors have similar mechanical properties and common transduction mechanisms

Recombinant adeno-associated virus as delivery vector for gene therapy--a review.

Adeno-associated virus vector as a platform for gene therapy delivery

High-Density Recombinant Adeno-Associated Viral Particles are Competent Vectors for In Vivo Transduction.

High-Titer Adeno-Associated Viral Vectors from a Rep/Cap Cell Line and Hybrid Shuttle Virus

The Characterization of Modified Adenovirus Vector

The evolution of adenoviral vectors through genetic and chemical surface modifications